"EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom (ENgAGE - UK): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK"

CompletedOBSERVATIONAL
Enrollment

99,999

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

May 31, 2019

Conditions
Prevention of Oesophagus Cancer and Stomach Cancer
Interventions
DRUG

Acetylsalicylic Acid(BAYE4465, Aspirin )

Administration according to clinical practice

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY